MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$43,540K
EPS
-$0.39
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Research and development
37,353 26,480* 39,824 37,638
General and administrative
6,943 7,019* 6,764 8,268
Total operating expenses
44,296 33,499 46,588 45,906
Loss from operations
-44,296 -33,499* -46,588 -45,906
Interest income
1,076 1,204* 1,808 1,410
Interest expense
636 272* 584 571
Other income, net
341 -297* 498 -61
Net loss
-43,515 -32,864* -44,866 -45,128
Net unrealized gain on available-for-sale investments, net of tax
-25 -9* 22 1
Net comprehensive loss
-43,540 -32,874 -44,844 -45,127
Basic EPS
-0.39 -5.479 -0.44 -0.73
Diluted EPS
-0.39 -0.525* -0.44 -0.73
Basic Average Shares
112,025,474 6,000,000 --
Diluted Average Shares
112,025,474 ---
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net comprehensiveloss-$43,540K Net loss-$43,515K Net unrealized gainon...-$25K Interest income$1,076K Other income, net$341K Loss from operations-$44,296K Interest expense$636K Total operatingexpenses$44,296K Research and development$37,353K General andadministrative$6,943K

Cabaletta Bio, Inc. (CABA)

Cabaletta Bio, Inc. (CABA)